F. Hoffmann-La Roche Ltd (batch release; secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of adults with chronic lymphocytic leukemia (in combination with chlorambucil), as well as for the treatment of patients with follicular lymphoma (both in combination with chemotherapy and as maintenance therapy).
Dosage form: concentrate for infusion solution
Active substance Dosage obinutuzumab 25 mg/ml ATC: L01FA03